ISouth Africa Delivery, iDaily Domestic Delivery, I-European Domestic Delivery

I-Rimonabant powder

Akukho kalo
5.00 ngaphandle kwe 5 ngenxa ye 1 ireyithingi abathengi
SKU: 168273-06-1. Udidi:

I-AASraw inokubaniswa kunye nokukwazi ukuvelisa kwigram ukuya kwi-mass order ye-Rimonabant powder (i-168273-06-1), phantsi komgaqo weCGMP kunye nolawulo lwekhwalithi ephezulu.

Ingcaciso yeMveliso

Rimonabant powder ividiyo


I-Rimonabant powder ezisisiseko

igama: I-Rimonabant powder
CAS: 168273-06-1
I-molecular Formula: C22H21Cl3N4O
Isisindo somzimba: 463.79
Melt Point: 230-240ºC
Isitoreji sokugcina: Ifriji
umbala: I-White okanye i-white powstalline powder


I-Raw Rimonabant emanzini amaninzi ekulahlekeni kwexabiso

Amagama

I-Rimonabant powder (i-CAS 168273-06-1) isilwanyana esingasondeli sokunyuka kwesantya esiveliswa kwaye sithengiswa nguSanofi-Aventis. I-agonist inverse ye-receptor ye-cannabinoid CB1. Isiphumo esona siphumelelo sinciphisa ukutya. I-Rimonabant powder yiyona yokuqala ye-CB1 receptor blocker eya kuvunywa ukuba isebenziswe naphi na emhlabeni.

Ukusetyenziswa kweRimonabant powder

I-powder Rimonabant iyatholakala kwi dose ephantsi ye-5mg ukuya kumlinganiselo ophezulu we-20mg. Imfuno yakho kunye nendlela yokulawula ngayo kufuneka ivela kwingcebiso yongcali yokutya. I-Rimonabant powder ayilungiselelwe ukuba isebenze yodwa. Yenzelwe ukuba isetyenziswe ngokubambisana nokutya okufanelekileyo kunye nokuzivocavoca ukuphucula impilo yomntu ngelixa uyanciphisa ubungakanani bentambo yakho.

Ziziphi iindidi zeMveliso endiyilindeleyo kwi-Raw Rabonabant powder

I-Acomplia yaphuhliswa ukuphatha abantu abagqithiseleyo kunye nokugqithisa ngokugqithisa ukusebenzisa okongeza ukuzilolonga nokutya. Izigulane, ezigulayo ngamanqanaba amaninzi eoli kunye ne-diabetes ye-2nd uhlobo.

I-Acomplia nayo yathonywa nguSanofy njengesifo esingayeka ukuqala kwesifo senhliziyo. Abantu abanomlenze omkhulu (abafazi be-88 cm kunye namadoda e-102 cm) bathenjiswe ukuba bafumane inzuzo enkulu ekusebenziseni eli liyeza.

Ukuyeka ukutshaya Kuye kwabonakaliswa ukuba i-Rimonabant powder ingabancedisa abantu ababhema ukuyeka ukutshaya. Okwangoku, i-Sanofi-Aventis yenza uphando ukuba iqinisekise ukuba i-Rimonabant powder iyinokwenzeka unyango lokuyeka ukutshaya. Iprogram ye-STRATUS (Izifundo kunye ne-Rimonabant powder kunye nokusetyenziswa kweTuba) kunezifundo ezingaphezulu kwe-6,000. Le nkqubo ihlola iindlela ezimbini zokwelapha ezihlobene nokutshaya. Okokuqala kukunceda umntu otshaya ukuyeka. Inkqubo yesibini kukukhusela ukuyeka ukuzuza ubunzima.

Kubonakala ukuba iziphumo zokuqala zibonise ukuba i-Rimonabant powder iyasebenza kwiinkqubo zombini. I-Sanofi-Aventis ifumene inkcazo ecacileyo esuka kwi-FDA yokuba abayiyi kuvumela ukuba athengise i-Rimonabant powder e-United States njengemithi yokuyeka umsi ngaphandle kwezofundo ezongezelelweyo. Ukuhlaziywa kwe-2007 nguCchrane kubonise ukuba i-Rimonabant powder ingancedisa ukuyeka ukutshaya kunye neengxaki malunga ne-11 / 2.

ukuXhomekeka
I-Rimonabant powder iyancipha isenzo sokuqala kwakhona kweempendulo ngokufuna i-cocaine eqaliswe ngu-2 ngaphandle kwe-3 kakhulu ebenziwayo abasebenza ngokuphindaphindiweyo abantu ababenayo. Ziyinto yokuqhayisa kunye neyokuqala. Iyakwazi ukunciphisa ukuziphatha kokufuna i-opiate kunye ne-ethanol.

Khumbuzo
I-Tetrahydrocannabinol yinto eyenzayo yokunciphisa imemori yakho emfutshane. Kwakukho ingcamango yokuba i-Rimonabant powder (i-CAS 168273-06-1) ingenza imemori yesikhashana ibe ngcono. Ukunyamekela izifundo zezilwanyana, iinkozi zibonise umphumo omangalisayo ngokufakela ulwazi kwiimemori zabo ezifutshane.

Isilumkiso kwi-Raw Rabonabant powder

Ngo-Oktobha 2008, iAcomplia iipilisi zalahlekelwa yilayisenisi kulo lonke elaseYurophu. Iyeza linike ingozi echongezelayo inzuzo yokuyisebenzisa. Kwaqatshelwa ukuba i-Acomplia inefuthe elibi kakhulu, elinengxaki yengxaki yengqondo. Ngokuqhelekileyo kwakuxinezelekile. Uhlalutyo olwenziwe kungekudala lubonise ukuba umngcipheko kwesi sifo sikhulu kunokuba kuthethwe ekuqaleni. Ucwaningo lubonise ukuba ukuba uthelekisa iimeko ezimbini zokusebenzisa iAcomplia kunye nokusebenzisa i-placebo, umngcipheko wokuba neengxaki zengqondo ziphindwe kabini kwi-Acomplia kunezinye.

Emva kokuba umkhiqizo wenziwe kwaye uqaliswe emarike, ezinye iingcebiso kunye nezindlela zekliniki zaphunyezwa. Akukazanga ukunciphisa umngcipheko kunye nokuphindaphinda kwezi ziphumo. Ezinye iimvavanyo zabaprofesa baseYurophu babonisa ukuba akukho mingcipheko enokunciphisa umngcipheko wokuba neengxaki. Emva koko, loo mveliso ithathwe kwiimarike zaseYurophu. Ufanele uthethe ugqirha xa kukulungele, ukuba usebenzisa i-Acomplia kwaye uxoxe ngonyango. Nangona kunjalo, unokugqiba ukuthatha uAcomplia naluphi na ixesha ofuna.

Ngexesha leemvavanyo zonyango kuye kwaqulunqwa ukuba abo bagulane abaqhubekayo unyango bahlaziya isisindo. Abo, abayekile ukunyango, ngokukhawuleza baba malunga nesiqingatha sobunzima emva, emva kokuyeka. Kufuneka ukhumbule ukugcina ukutya kwaye usebenzise xa unyango lwakho nangemva kwalo. Kuya kukunceda ulahle ngakumbi ubunzima bakho. Ukusebenza kunye nokukhuseleko akuzange kufundwe kwabo bathathe iyeza iminyaka engaphezu kweminyaka emibili. I-Acomplia inokukunceda ube nesigxina sokuguquka kwemiqobo kunye neempawu zokudandatheka. Kufuneka uqhagamshelane nodokotela wakho ngokukhawuleza kwaye uyeke ukuthabatha iziyobisi, ukuba uqaphele ukuba awunelisekanga ngobomi bakho okanye unesivakalelo kunye nokucinga.

UAcomplia wafundiswa eMelika iminyaka emibini. Bafumanisa iziphumo ezinjengeemeko ezixinezelekileyo, zithukuthele kwaye zixhalabise lonke ixesha. Ukusetyenziswa okuqhubekayo kwezi ziza kwenza iziphumo ezinobungozi. Yingakho i-FDA ingazange iyivume.

I-Acomplia ivunyiwe yi-EU kwi-2006. Kamva, bayithatha emarike ngenxa yokuba kwakukho iziganeko ezixeliweyo iingxaki ezinzulu kunye nombuso wengqondo, kwimeko yokuzibulala.

Abantu abasebenzisa iAcomplia babike ngezinye iziphumo ezibi:
Uxinzelelo oluphezulu lwegazi
Kwimeko yokukhathazeka okukhulu nokukhathazeka
Ukungakwazi ukulala
Ukuxinezeleka
Petulance
Ukunyaniseka
Emetic

I mi yalelo

I-Synephrine, okanye njengoko iyazi ngokuqhelekileyo, i-Bitter Orange, isityalo apho iqabunga, iziqhamo kunye nejusi yesithelo zivunwa kwaye zisetyenziselwa ukwenza iyeza kunye ne-peel ngokwayo isetyenziselwa ukwenza ioli. Ioli ye-orange enomsindo ingasetyenziselwa ulusu ukunceda ukunyanga izifo, ezinjengeengqungquthela kunye nabadlali beenyawo.

Nangona uphando oluninzi luqhutyelwa, kukho ubungqina obaneleyo bokubonisa ukuba xa umntu edla inani elaneleyo lomnxeba, unamandla okukhusela ukutya. Yilapho i-synephrine ibonisa iimpawu zokulahlekelwa kwesisindo phakathi kwabasebenzisi njengoko idala umphumo ongapheliyo emzimbeni ukwenzela ukuba umthengi azive epheleleyo ixesha elide kwaye unciphise nasiphi na isilingo ngenxa yokuthanda okanye umnqweno wokutya ukutya okunye. Ngokutya ukutya okuncinci, udla iikhalori ezingaphantsi, eziza kubangela ukulahleka kwesisindo ngexesha elide.

I-Rimonabant Raw Powder (i-CAS 168273-06-1)

I-10grams encinci.
Uphando malunga nobukhulu obuqhelekileyo (ngaphakathi kwe-1kg) lungathunyelwa kwiiyure ze-12 emva kokuhlawula.
Ukwenza umyalelo omkhulu ungathunyelwa kwiintsuku zokusebenza ze-3 emva kokuhlawula.

I-Raw Rabonabant yokuthengisa

Ukubonelelwa kwikamva elizayo.


Indlela yokuthenga i-Rimonabant powder (CAS 168273-06-1) esuka kwi-AASraw

1.Qhagamshelana nathi nge-imeyile yethu inkqubo yophando, okanye i-skype ye-intanethiummeli wenkonzo yamakhasimende (CSR).
2.Ukusibonelela ngobuninzi bakho kunye neadesi.
I-3.I-CSR yethu iya kukunika isingeniso, ixesha lokuhlawula, inombolo yokulandelela, iindlela zokuhambisa kunye nomhla wokufika oqikelelwayo (i-ETA).
I-4.Inkokhelo eyenziwe kwaye iimpahla ziya kuthunyelwa kwiiyure ze-12 (Ukuze ulandelwe ngaphakathi kwe-10kg).
5.Goods zifunyenwe kwaye zinike izimvo.


=

IAAA

I-COA 168273-06-1 I-Rimonabant AASRAW

HNMR

Recipes

Ukupheka kweeRowonabant Raw Powder:

Ukubuza ummeli wethu ummeli (Representative Representative) (CSR) ngeenkcukacha, ngokubhekiselele kuyo.

Iziqulatho kunye nokuqulunqwa kwemveliso

I-supplementary loss loss supplement- i-Rimonabant powder